Skip to Content

20 Results Found

  • Article
  • Open Access
9 Citations
4,777 Views
19 Pages

A Combination of Conformation-Specific RAF Inhibitors Overcome Drug Resistance Brought about by RAF Overexpression

  • Hiroaki Imoto,
  • Nora Rauch,
  • Ashish J. Neve,
  • Fahimeh Khorsand and ,
  • Martina Kreileder,
  • Leonidas G. Alexopoulos,
  • Jens Rauch,
  • Mariko Okada,
  • Boris N. Kholodenko and
  • Oleksii S. Rukhlenko
  • + 5 authors+ 0 author

2 August 2023

Cancer cells often adapt to targeted therapies, yet the molecular mechanisms underlying adaptive resistance remain only partially understood. Here, we explore a mechanism of RAS/RAF/MEK/ERK (MAPK) pathway reactivation through the upregulation of RAF...

(This article belongs to the Section Enzymology)
  • Article
  • Open Access
6 Citations
3,259 Views
14 Pages

Targeting RAF Isoforms and Tumor Microenvironments in RAS or BRAF Mutant Colorectal Cancers with SJ-C1044 for Anti-Tumor Activity

  • Sungpyo Hong,
  • Myeongjin Jeon,
  • Jeonghee Kwon,
  • Hanbyeol Park and ,
  • Goeun Lee,
  • Kilwon Kim and
  • Soonkil Ahn
  • + 2 authors+ 0 author

Colorectal cancer (CRC) is a significant global health issue characterized by a high prevalence of KRAS gene mutations. The RAS/MAPK pathway, involving KRAS, plays a crucial role in CRC progression. Although some RAS inhibitors have been approved, th...

(This article belongs to the Special Issue Molecular-Based Approaches in Therapy for Gastrointestinal Cancers, 2nd Edition)
  • Review
  • Open Access
43 Citations
9,106 Views
20 Pages

The Ras-Raf-MEK-ERK signaling pathway, the first well-established MAPK pathway, plays essential roles in cell proliferation, survival, differentiation and development. It is activated in over 40% of human cancers owing to mutations of Ras, membrane r...

(This article belongs to the Topic Kinases in Cancer and Other Diseases)
  • Article
  • Open Access
26 Citations
4,142 Views
18 Pages

31 March 2019

Background and objectives: Cancer represents the miscommunication between and within the body cells. The mutations of the oncogenes encoding the MAPK pathways play an important role in the development of tumoral diseases. The mutations of KRAS and BR...

  • Review
  • Open Access
125 Citations
26,239 Views
35 Pages

Progress on Ras/MAPK Signaling Research and Targeting in Blood and Solid Cancers

  • Martha Dillon,
  • Antonio Lopez,
  • Edward Lin,
  • Dominic Sales and ,
  • Ron Perets and
  • Pooja Jain
  • + 1 author+ 0 author

10 October 2021

The mitogen-activated protein kinase (MAPK) pathway, consisting of the Ras-Raf-MEK-ERK signaling cascade, regulates genes that control cellular development, differentiation, proliferation, and apoptosis. Within the cascade, multiple isoforms of Ras a...

  • Review
  • Open Access
17 Citations
7,114 Views
15 Pages

RSK Isoforms in Acute Myeloid Leukemia

  • Minyoung Youn,
  • Jesus Omar Gomez,
  • Kailen Mark and
  • Kathleen M. Sakamoto

Ribosomal S6 Kinases (RSKs) are a group of serine/threonine kinases that function downstream of the Ras/Raf/MEK/ERK signaling pathway. Four RSK isoforms are directly activated by ERK1/2 in response to extracellular stimuli including growth factors, h...

(This article belongs to the Special Issue Acute Myeloid Leukemia: From Pathophysiology to Novel Therapeutic Approaches)
  • Feature Paper
  • Review
  • Open Access
45 Citations
7,988 Views
18 Pages

6 November 2020

Ras is the most frequently mutated oncogene and recent drug development efforts have spurred significant new research interest. Here we review progress toward understanding how Ras functions in nanoscale, proteo-lipid signaling complexes on the plasm...

(This article belongs to the Special Issue Recent Insights into the Regulation and Structure of RAS Membrane Signaling Complexes—Emerging Drug Targeting Opportunities)
  • Article
  • Open Access
24 Citations
7,403 Views
13 Pages

Both ERK1 and ERK2 Are Required for Enterovirus 71 (EV71) Efficient Replication

  • Meng Zhu,
  • Hao Duan,
  • Meng Gao,
  • Hao Zhang and
  • Yihong Peng

20 March 2015

It has been demonstrated that MEK1, one of the two MEK isoforms in Raf-MEK-ERK1/2 pathway, is essential for successful EV71 propagation. However, the distinct function of ERK1 and ERK2 isoforms, the downstream kinases of MEKs, remains unclear in EV...

(This article belongs to the Special Issue Viral Replication Complexes: Structures, Functions, Applications and Inhibitors)
  • Review
  • Open Access
60 Citations
11,350 Views
20 Pages

ERK1 and ERK2 (ERKs), two extracellular regulated kinases (ERK1/2), are evolutionary-conserved and ubiquitous serine-threonine kinases involved in regulating cell signalling in normal and pathological tissues. The expression levels of these kinases a...

(This article belongs to the Special Issue ERK Signaling Pathway in Diseases)
  • Article
  • Open Access
19 Citations
9,966 Views
17 Pages

In Vitro Glucuronidation of Wushanicaritin by Liver Microsomes, Intestine Microsomes and Expressed Human UDP-Glucuronosyltransferase Enzymes

  • Xiaodan Hong,
  • Yuanru Zheng,
  • Zifei Qin,
  • Baojian Wu and ,
  • Yi Dai,
  • Hao Gao,
  • Zhihong Yao,
  • Frank J. Gonzalez and
  • Xinsheng Yao
  • + 4 authors+ 0 author

19 September 2017

Wushanicaritin, a natural polyphenol compound, exerts many biological activities. This study aimed to characterize wushanicaritin glucuronidation by pooled human liver microsomes (HLM), human intestine microsomes and individual uridine diphosphate-gl...

(This article belongs to the Section Biochemistry)
  • Review
  • Open Access
67 Citations
5,828 Views
8 Pages

Role of BRAF in Hepatocellular Carcinoma: A Rationale for Future Targeted Cancer Therapies

  • Antonio Gnoni,
  • Antonella Licchetta,
  • Riccardo Memeo,
  • Antonella Argentiero and ,
  • Antonio G. Solimando,
  • Vito Longo,
  • Sabina Delcuratolo and
  • Oronzo Brunetti
  • + 3 authors+ 0 author

21 November 2019

The few therapeutic strategies for advance hepatocellular carcinoma (HCC) on poor knowledge of its biology. For several years, sorafenib, a tyrosine kinase inhibitors (TKI) inhibitor, has been the approved treatment option, to date, for advanced HCC...

  • Article
  • Open Access
2 Citations
3,836 Views
19 Pages

Screening Methods to Discover the FDA-Approved Cancer Drug Encorafenib as Optimally Selective for Metallothionein Gene Loss Ovarian Cancer

  • Amy Rees,
  • Evan Villamor,
  • Della Evans,
  • Monika Gooz and ,
  • Clare Fallon,
  • Mirna Mina-Abouda,
  • Andrew Disharoon,
  • Scott T. Eblen and
  • Joe R. Delaney
  • + 4 authors+ 0 author

1 January 2025

Background/Objectives: All 11 metallothionein protein-coding genes are located on human chromosome 16q13. It is unique among human genetics to have an entire pathway’s genes clustered in a short chromosomal region. Since solid tumors, particula...

(This article belongs to the Section Molecular Genetics and Genomics)
  • Article
  • Open Access
6 Citations
2,260 Views
11 Pages

Colorectal cancer (CRC), found in the intestinal tract, is initiated and progresses through various mechanisms, including the dysregulation of signaling pathways. Several signaling pathways, such as EGFR and MAPK, involved in cell proliferation, migr...

(This article belongs to the Collection Bioinformatics Approaches to Biomedicine)
  • Article
  • Open Access
7 Citations
4,978 Views
15 Pages

Cellular senescence is a state of terminal proliferative arrest that plays key roles in aging by preventing stem cell renewal and by inducing the expression of a series of inflammatory factors including many secreted proteins with paracrine effects....

  • Review
  • Open Access
13 Citations
4,855 Views
25 Pages

26 May 2023

The development of RNA sequencing methods has allowed us to study and better understand the landscape of aberrant pre-mRNA splicing in tumors. Altered splicing patterns are observed in many different tumors and affect all hallmarks of cancer: growth...

(This article belongs to the Section Molecular Cancer Biology)
  • Article
  • Open Access
6 Citations
2,989 Views
24 Pages

17 November 2021

Abnormalities of the MAPK pathway play vital roles in cancer initiation and progression. RAS GTPases that are key upstream mediators of the pathway are mutated in 30% of human cancers. Polyisoprenylated cysteinyl amide inhibitors (PCAIs) were designe...

(This article belongs to the Special Issue Targeting KRAS: Elucidating Mechanisms of Sensitivity and Resistance)
  • Review
  • Open Access
72 Citations
11,045 Views
16 Pages

Understanding the Mechanisms of Resistance in EGFR-Positive NSCLC: From Tissue to Liquid Biopsy to Guide Treatment Strategy

  • Marzia Del Re,
  • Stefania Crucitta,
  • Giulia Gianfilippo,
  • Antonio Passaro and ,
  • Iacopo Petrini,
  • Giuliana Restante,
  • Angela Michelucci,
  • Stefano Fogli,
  • Filippo de Marinis and
  • Romano Danesi
  • + 7 authors+ 2 authors

14 August 2019

Liquid biopsy has emerged as an alternative source of nucleic acids for the management of Epidermal Growth Factor Receptor (EGFR)-mutant non-Small Cell Lung Cancer (NSCLC). The use of circulating cell-free DNA (cfDNA) has been recently introduced in...

(This article belongs to the Special Issue Advances in the Comprehension of the Molecular Basis of Cancer and New Therapeutic Strategies)
  • Article
  • Open Access
1 Citations
2,685 Views
32 Pages

KRAS is a pivotal oncoprotein that regulates cell proliferation and survival through interactions with downstream effectors such as RAF1. Despite significant advances in understanding KRAS biology, the structural and dynamic mechanisms of KRAS allost...

(This article belongs to the Special Issue Computational Analysis and Conformational Modeling for Protein Structure and Interaction)
  • Article
  • Open Access
36 Citations
5,762 Views
16 Pages

High Sensitivity of Circulating Tumor Cells Derived from a Colorectal Cancer Patient for Dual Inhibition with AKT and mTOR Inhibitors

  • Daniel J. Smit,
  • Laure Cayrefourcq,
  • Marie-Therese Haider,
  • Nico Hinz and ,
  • Klaus Pantel,
  • Catherine Alix-Panabières and
  • Manfred Jücker
  • + 2 authors+ 0 author

20 September 2020

Circulating tumor cells (CTCs) are cells shed from the primary tumor into the bloodstream. While many studies on solid tumor cells exist, data on CTCs are scarce. The mortality of cancer is mostly associated with metastasis and recent research identi...

(This article belongs to the Section Cell Signaling)
  • Article
  • Open Access
34 Citations
7,448 Views
19 Pages

Understanding the Interplay between COX-2 and hTERT in Colorectal Cancer Using a Multi-Omics Analysis

  • Georgios D. Ayiomamitis,
  • George Notas,
  • Thivi Vasilakaki,
  • Aikaterini Tsavari and ,
  • Styliani Vederaki,
  • Theodosis Theodosopoulos,
  • Elias Kouroumalis and
  • Apostolos Zaravinos
  • + 3 authors+ 0 author

11 October 2019

Background: Cyclooxygenase 2 (COX-2) is involved in the initial steps of colorectal cancer (CRC) formation, playing a key role in the catalysis of arachidonic acid to prostaglandin E2 (PGE2). The human telomerase reverse transcriptase (hTERT or TERT)...

(This article belongs to the Special Issue The Role of Telomeres and Telomerase in Cancer)